Johnson & Johnson

JNJ · Health Care · Market cap $618B

Q2 FY26 Jun 28, 2026 reported Jul 23, 2026

Revenue$25.3B +7% year over year

Gross profit$17.3B

Operating profit$7.2B

Net profit$5.5B 22% margin

Numbers and detail

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 28, 2026).
Item	Value	Share of revenue	Year over year
Revenue	25.3	100%	+7%
Innovative Medicine	16.4	65%	+8%
Med Tech	8.9	35%	+5%
Cost of revenue	−8.1	32%
Gross profit	17.3	68% margin	+0pp
SG&A	−6.4	25%	+1pp
Other	−3.7	14%	+0pp
Operating profit	7.2	28% margin	+0pp
Tax	−1.3
Interest & other costs	−0.4
Net profit	5.5	22%	−1pp

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 29, 2026).
Item	Value	Share of revenue	Year over year
Revenue	24.1	100%	+10%
Innovative Medicine	15.4	64%	+11%
Med Tech	8.6	36%	+8%
Cost of revenue	−8.1	34%
Gross profit	16	66% margin	+0pp
SG&A	−6	25%	+2pp
Other	−3.5	15%	+0pp
Operating profit	6.4	27% margin	+0pp
Tax	−0.8
Interest & other costs	−0.4
Net profit	5.2	22%	−28pp

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 28, 2025).
Item	Value	Share of revenue	Year over year
Revenue	24	100%	+7%
Innovative Medicine	15.6	65%	+7%
Med Tech	8.4	35%	+7%
Cost of revenue	−7.3	30%
Gross profit	16.7	70% margin	+1pp
SG&A	−5.9	25%	+0pp
Other	−3.7	15%	+0pp
Operating profit	7.1	30% margin	+0pp
Tax	−2.3
Net profit	5.2	21%	+9pp

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 29, 2025).
Item	Value	Share of revenue	Year over year
Revenue	23.7	100%	+6%
Innovative Medicine	15.2	64%	+5%
Med Tech	8.5	36%	+7%
Cost of revenue	−7.6	32%
Gross profit	16.1	68% margin	−2pp
SG&A	−5.9	25%	−1pp
Other	−3.5	15%	+0pp
Operating profit	6.7	28% margin	+0pp
Tax	−1
Interest & other costs	−0.2
Net profit	5.5	23%	+2pp

Quarter by quarter

Pick a quarter and the diagram above changes. Bars compare revenue across the quarters we hold.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q2 FY26	Jun 28, 2026	Jul 23, 2026	$25.3B	+7%	28%	$5.5B	22%
Q1 FY26	Dec 29, 2025 – Mar 29, 2026	Apr 22, 2026	$24.1B	+10%	27%	$5.2B	22%
Q3 FY25	Jun 30 – Sep 28, 2025	Oct 22, 2025	$24B	+7%	30%	$5.2B	21%
Q2 FY25	Mar 31 – Jun 29, 2025	Jul 24, 2025	$23.7B	+6%	28%	$5.5B	23%